Concepedia

Author

Jianming He

Janssen (United States)

Also Known As

He, Jianming, J He, J. He, Jianming He

80

Publications

1.1K

Citations

16

H-Index

27

Concepts

All Affiliations

Janssen (United States)Janssen (Belgium)Levine Cancer InstituteJanssen Scientific Affairs (United States)Janssen (Netherlands)
JH

About

Jianming He is an author at Janssen (United States) specializing in medicine, oncology, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

91

2

Health Sciences

2

2

53

3

Education

1

1

63

4

Engineering

1

1

17

5

Biostatistics

1

1

17

Jianming He

×

20

Publications

558

Citations

14

H-Index

YearCitations

Frontline treatment patterns and attrition rates by subsequent lines of therapy in patients with newly diagnosed multiple myeloma

Rafaël Fonseca, Saad Z. Usmani, Maneesha Mehra,

BMC Cancer

2020

108

Validation of a Contemporary Five-tiered Gleason Grade Grouping Using Population-based Data

Jianming He, Peter C. Albertsen, Dirk F. Moore,

European Urology

2016

63

Patient characteristics and outcomes after ruxolitinib discontinuation in patients with myelofibrosis

John Mascarenhas, Maneesha Mehra, Jianming He,

Journal of Medical Economics

2020

54

Health-Related Quality of Life in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: Findings From the Phase III MAIA Trial

Aurore Perrot, Thierry Façon, Torben Plesner,

Journal of Clinical Oncology

2020

40

Validation of economic and health outcomes simulation model of type 2 diabetes mellitus (ECHO-T2DM)

Michael Willis, Christian Asseburg, Jianming He

Journal of Medical Economics

2013

34

Decitabine reduces transfusion dependence in older patients with acute myeloid leukemia: results from a<i>post hoc</i>analysis of a randomized phase III study

Jianming He, Liang Xiu, Peter De Porre,

Leukemia & lymphoma/Leukemia and lymphoma

2014

34

Daratumumab Improves Depth of Response and Progression-free Survival in Transplant-ineligible, High-risk, Newly Diagnosed Multiple Myeloma

Andrzej Jakubowiak, Shaji Kumar, Rohan Medhekar,

The Oncologist

2022

30

Impact of Treatment Sequencing on Overall Survival in Patients with Transplant-Ineligible Newly Diagnosed Myeloma

Rafaël Fonseca, Thierry Façon, Mahmoud Hashim,

The Oncologist

2023

25

Survival outcomes in myelofibrosis patients treated with ruxolitinib: A population‐based cohort study in Sweden and Norway

Frida Schain, Emese Vágó, Ci Song,

European Journal Of Haematology

2019

21

Patient-reported outcomes predict overall survival in older patients with acute myeloid leukemia

John Devin Peipert, Fabio Efficace, Renee F. Pierson,

Journal of Geriatric Oncology

2021

19

Page 1